Your browser doesn't support javascript.
loading
Mapping genomic loci implicates genes and synaptic biology in schizophrenia.
Trubetskoy, Vassily; Pardiñas, Antonio F; Qi, Ting; Panagiotaropoulou, Georgia; Awasthi, Swapnil; Bigdeli, Tim B; Bryois, Julien; Chen, Chia-Yen; Dennison, Charlotte A; Hall, Lynsey S; Lam, Max; Watanabe, Kyoko; Frei, Oleksandr; Ge, Tian; Harwood, Janet C; Koopmans, Frank; Magnusson, Sigurdur; Richards, Alexander L; Sidorenko, Julia; Wu, Yang; Zeng, Jian; Grove, Jakob; Kim, Minsoo; Li, Zhiqiang; Voloudakis, Georgios; Zhang, Wen; Adams, Mark; Agartz, Ingrid; Atkinson, Elizabeth G; Agerbo, Esben; Al Eissa, Mariam; Albus, Margot; Alexander, Madeline; Alizadeh, Behrooz Z; Alptekin, Köksal; Als, Thomas D; Amin, Farooq; Arolt, Volker; Arrojo, Manuel; Athanasiu, Lavinia; Azevedo, Maria Helena; Bacanu, Silviu A; Bass, Nicholas J; Begemann, Martin; Belliveau, Richard A; Bene, Judit; Benyamin, Beben; Bergen, Sarah E; Blasi, Giuseppe; Bobes, Julio.
Afiliação
  • Trubetskoy V; Department of Psychiatry and Psychotherapy, Charité - Universitätsmedizin, Berlin, Germany.
  • Pardiñas AF; MRC Centre for Neuropsychiatric Genetics and Genomics, Division of Psychological Medicine and Clinical Neurosciences, Cardiff University, Cardiff, UK.
  • Qi T; Institute for Molecular Bioscience, University of Queensland, Brisbane, Queensland, Australia.
  • Panagiotaropoulou G; School of Life Sciences, Westlake University, Hangzhou, China.
  • Awasthi S; Department of Psychiatry and Psychotherapy, Charité - Universitätsmedizin, Berlin, Germany.
  • Bigdeli TB; Department of Psychiatry and Psychotherapy, Charité - Universitätsmedizin, Berlin, Germany.
  • Bryois J; Department of Psychiatry and the Behavioral Sciences, SUNY Downstate Medical Center, New York, NY, USA.
  • Chen CY; Institute for Genomic Health, SUNY Downstate Medical Center, New York, NY, USA.
  • Dennison CA; Department of Psychiatry, Veterans Affairs New York Harbor Healthcare System, New York, NY, USA.
  • Hall LS; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
  • Lam M; Biogen, Cambridge, MA, USA.
  • Watanabe K; Analytic and Translational Genetics Unit, Massachusetts General Hospital, Boston, MA, USA.
  • Frei O; Psychiatric and Neurodevelopmental Genetics Unit, Center for Genomic Medicine, Massachusetts General Hospital, Boston, MA, USA.
  • Ge T; MRC Centre for Neuropsychiatric Genetics and Genomics, Division of Psychological Medicine and Clinical Neurosciences, Cardiff University, Cardiff, UK.
  • Harwood JC; MRC Centre for Neuropsychiatric Genetics and Genomics, Division of Psychological Medicine and Clinical Neurosciences, Cardiff University, Cardiff, UK.
  • Koopmans F; Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, MA, USA.
  • Magnusson S; Research Division, Institute of Mental Health, Singapore, Republic of Singapore.
  • Richards AL; Division of Psychiatry Research, Zucker Hillside Hospital, Glen Oaks, NY, USA.
  • Sidorenko J; Department of Complex Trait Genetics, Center for Neurogenomics and Cognitive Research, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
  • Wu Y; NORMENT Centre, Division of Mental Health and Addiction, University of Oslo, Oslo, Norway.
  • Zeng J; Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway.
  • Grove J; Center for Bioinformatics, Department of Informatics, University of Oslo, Oslo, Norway.
  • Kim M; Psychiatric and Neurodevelopmental Genetics Unit, Center for Genomic Medicine, Massachusetts General Hospital, Boston, MA, USA.
  • Li Z; Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, MA, USA.
  • Voloudakis G; Department of Psychiatry, Harvard Medical School, Boston, MA, USA.
  • Zhang W; MRC Centre for Neuropsychiatric Genetics and Genomics, Division of Psychological Medicine and Clinical Neurosciences, Cardiff University, Cardiff, UK.
  • Adams M; Department of Molecular and Cellular Neurobiology, Center for Neurogenomics and Cognitive Research, Faculty of Science, Amsterdam Neuroscience, Vrije Universiteit, Amsterdam, The Netherlands.
  • Agartz I; deCODE Genetics, Amgen, Reykjavik, Iceland.
  • Atkinson EG; MRC Centre for Neuropsychiatric Genetics and Genomics, Division of Psychological Medicine and Clinical Neurosciences, Cardiff University, Cardiff, UK.
  • Agerbo E; Institute for Molecular Bioscience, University of Queensland, Brisbane, Queensland, Australia.
  • Al Eissa M; Institute for Molecular Bioscience, University of Queensland, Brisbane, Queensland, Australia.
  • Albus M; Institute for Molecular Bioscience, University of Queensland, Brisbane, Queensland, Australia.
  • Alexander M; The Lundbeck Foundation Initiative for Integrative Psychiatric Research (iPSYCH), Aarhus, Denmark.
  • Alizadeh BZ; Department of Biomedicine and Centre for Integrative Sequencing (iSEQ), Aarhus University, Aarhus, Denmark.
  • Alptekin K; Center for Genomics and Personalized Medicine, Aarhus, Denmark.
  • Als TD; Department of Psychiatry, Semel Institute, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA.
  • Amin F; Affiliated Hospital of Qingdao University and Biomedical Sciences Institute of Qingdao University (Qingdao Branch of SJTU Bio-X Institutes), Qingdao University, Qingdao, China.
  • Arolt V; Bio-X Institutes, Key Laboratory for the Genetics of Developmental and Neuropsychiatric Disorders (Ministry of Education), Collaborative Innovation Center for Brain Science, Shanghai Jiao Tong University, Shanghai, China.
  • Arrojo M; Department of Psychiatry, Pamela Sklar Division of Psychiatric Genomics, Friedman Brain Institute, Department of Genetics and Genomic Science and Institute for Data Science and Genomic Technology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Athanasiu L; Department of Psychiatry, Pamela Sklar Division of Psychiatric Genomics, Friedman Brain Institute, Department of Genetics and Genomic Science and Institute for Data Science and Genomic Technology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Azevedo MH; Department of Genetics and Genomic Sciences and Institute for Genomics and Multiscale Biology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Bacanu SA; Division of Psychiatry, Centre for Clinical Brain Sciences, University of Edinburgh, Royal Edinburgh Hospital, Edinburgh, UK.
  • Bass NJ; NORMENT Centre, Division of Mental Health and Addiction, University of Oslo, Oslo, Norway.
  • Begemann M; Department of Psychiatric Research, Diakonhjemmet Hospital, Oslo, Norway.
  • Belliveau RA; Centre for Psychiatry Research, Department of Clinical Neuroscience, Karolinska Institutet and Stockholm Health Care Services, Stockholm Region, Stockholm, Sweden.
  • Bene J; Analytic and Translational Genetics Unit, Massachusetts General Hospital, Boston, MA, USA.
  • Benyamin B; Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, MA, USA.
  • Bergen SE; The Lundbeck Foundation Initiative for Integrative Psychiatric Research (iPSYCH), Aarhus, Denmark.
  • Blasi G; National Centre for Register-based Research, Aarhus University, Aarhus, Denmark.
  • Bobes J; Molecular Psychiatry Laboratory, Division of Psychiatry, University College London, London, UK.
Nature ; 604(7906): 502-508, 2022 04.
Article em En | MEDLINE | ID: mdl-35396580
Schizophrenia has a heritability of 60-80%1, much of which is attributable to common risk alleles. Here, in a two-stage genome-wide association study of up to 76,755 individuals with schizophrenia and 243,649 control individuals, we report common variant associations at 287 distinct genomic loci. Associations were concentrated in genes that are expressed in excitatory and inhibitory neurons of the central nervous system, but not in other tissues or cell types. Using fine-mapping and functional genomic data, we identify 120 genes (106 protein-coding) that are likely to underpin associations at some of these loci, including 16 genes with credible causal non-synonymous or untranslated region variation. We also implicate fundamental processes related to neuronal function, including synaptic organization, differentiation and transmission. Fine-mapped candidates were enriched for genes associated with rare disruptive coding variants in people with schizophrenia, including the glutamate receptor subunit GRIN2A and transcription factor SP4, and were also enriched for genes implicated by such variants in neurodevelopmental disorders. We identify biological processes relevant to schizophrenia pathophysiology; show convergence of common and rare variant associations in schizophrenia and neurodevelopmental disorders; and provide a resource of prioritized genes and variants to advance mechanistic studies.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Esquizofrenia / Estudo de Associação Genômica Ampla Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Esquizofrenia / Estudo de Associação Genômica Ampla Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article